Literature DB >> 25424480

Risk of thromboembolic events in atrial fibrillation with chronic kidney disease.

Wu-Tao Zeng1, Xiu-Ting Sun1, Kai Tang1, Wei-Yi Mei1, Li-Juan Liu1, Qing Xu1, Yun-Jiu Cheng2.   

Abstract

BACKGROUND AND
PURPOSE: Chronic kidney disease may increase the risk for ischemic stroke or systemic embolism in patients with nonvalular atrial fibrillation (AF). We conducted a meta-analysis to summarize all published studies to investigate the link between chronic kidney disease and risk of thromboembolic events in AF.
METHODS: We performed a literature search using MEDLINE (source PubMed, 1966 to July, 2014) and EMBASE (1980 to July 2014) with no restrictions. Pooled effect estimates were obtained by using random-effects meta-analysis.
RESULTS: Eighteen studies involving 538 479 patients and 41 719 incident thromboembolic events were identified. From the pooled analysis, AF patients with estimated glomerular filtration rate <60 mL/min compared with those with estimated glomerular filtration rate ≥60 mL/min experienced a significantly increased risk for developing thromboembolic events (relative risk, 1.62 [95% confidence interval, 1.40-1.87; P<0.001]). The annual rate of thromboembolic events increased by 0.41% (95% confidence interval, 0.17%-0.65%) for a 10 mL/min decrease in renal function. Addition of renal impairment to CHADS2 slightly improved the stroke risk stratification.
CONCLUSIONS: Impaired renal function is an independent predictor of stroke or systemic embolism in patients with nonvalvular AF. Consideration of renal function may improve stroke risk stratification in patients with AF.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; chronic kidney disease; ischemic stroke

Mesh:

Year:  2014        PMID: 25424480     DOI: 10.1161/STROKEAHA.114.006881

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

Review 1.  Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.

Authors:  Thomas F Deering
Journal:  J Atr Fibrillation       Date:  2017-04-30

2.  Low-Voltage Area at the Anterior Wall of the Left Atrium Is Associated With Thromboembolism in Atrial Fibrillation Patients With a Low CHA2DS2-VA Score.

Authors:  Xiangwei Ding; Mingfang Li; Hongwu Chen; Gang Yang; Fengxiang Zhang; Weizhu Ju; Kai Gu; Jianqing Li; Minglong Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-13

Review 3.  Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.

Authors:  Tze-Fan Chao; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2015-06-30

Review 4.  Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation.

Authors:  Wu-Tao Zeng; Zhi-Hao Liu; Zhu-Yu Li; Ming Zhang; Yun-Jiu Cheng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 5.  Left Atrium and Left Atrial Appendage Screening Prior to Atrial Fibrillation Ablation: A Comprehensive Review of the Literature.

Authors:  Nicholas J Serafini; Kousik Krishnan
Journal:  J Innov Card Rhythm Manag       Date:  2018-05-15

6.  Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial.

Authors:  Ying Bai; Alena Shantsila; Gregory Y H Lip
Journal:  J Arrhythm       Date:  2020-02-06

7.  Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.

Authors:  Yasuhiro Hamatani; Yugo Yamashita; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Gregory Y H Lip; Masaharu Akao
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

8.  Role of Early Repolarization Pattern in Increasing Risk of Death.

Authors:  Yun-Jiu Cheng; Xiao-Xiong Lin; Cheng-Cheng Ji; Xu-Miao Chen; Li-Juan Liu; Kai Tang; Su-Hua Wu
Journal:  J Am Heart Assoc       Date:  2016-09-26       Impact factor: 5.501

9.  Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?

Authors:  Anna Michalska; Iwona Gorczyca; Magdalena Chrapek; Agnieszka Kapłon-Cieślicka; Beata Uziębło-Życzkowska; Katarzyna Starzyk; Olga Jelonek; Monika Budnik; Monika Gawałko; Paweł Krzesiński; Agnieszka Jurek; Piotr Scisło; Janusz Kochanowski; Marek Kiliszek; Grzegorz Gielerak; Krzysztof J Filipiak; Grzegorz Opolski; Beata Wożakowska-Kapłon
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

10.  Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey.

Authors:  David Collister; Jeff S Healey; David Conen; K Scott Brimble; Claudio Rigatto; Ziv Harel; Manish M Sood; Michael Walsh
Journal:  Can J Kidney Health Dis       Date:  2019-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.